Trilaciclib for preventing myelosuppression caused by chemotherapy for extensive-stage small-cell lung cancer [ID6651] Consultation on suggested remit, draft scope and provisional stakeholder list of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results